Cornea and Ocular Surface Treatment
Authors:
- Maria P. De MiguelMMMaria P. De Miguel
- Jorge L. AlioJAJorge L. Alio
- Francisco Arnalich-MontielFAFrancisco Arnalich-Montiel
- Sherezade Fuentes-JulianSFSherezade Fuentes-Julian
- Laura de Benito-LlopisLBLaura de Benito-Llopis
- Francisco AmparoFAFrancisco Amparo
- Laurent BatailleLaurent Bataille
- 1 June 2010
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 5 (2) , 195-204
Abstract
In addition to being a protective shield, the cornea represents two thirds of the eyes refractive power. Corneal pathology can affect one or all of the corneal layers, producing corneal opacity. Although full corneal thickness keratoplasty has been the standard procedure, the ideal strategy would be to replace only the damaged layer. Current difficulties in corneal transplantation, mainly immune rejection and shortage of organ supply, place more emphasis on the development of artificial corneas. Bioengineered corneas range from prosthetic devices that solely address the replacement of the corneal function, to tissue-engineered hydrogels that allow regeneration of the tissue. Recently, major advances in the biology of corneal stem cells have been achieved. However, the therapeutic use of these stem cell types has the disadvantage of needing an intact stem cell compartment, which is usually damaged. In addition, long ex vivo culture is needed to generate enough cell numbers for transplantation. In the near future, combination of advanced biomaterials with cells from abundant outer sources will allow advances in the field. For the former, magnetically aligned collagen is one of the most promising ones. For the latter, different cell types will be optimal: 1) for epithelial replacement: oral mucosal epithelium, ear epidermis, or bone marrow- mesenchymal stem cells, 2) for stromal regeneration: adipose-derived stem cells and 3) for endothelial replacement, the possibility of in vitro directed differentiation of adipose-derived stem cells towards endothelial cells provides an exciting new approach.Keywords
This publication has 59 references indexed in Scilit:
- Stem cells of the adult cornea: From cytometric markers to therapeutic applicationsCytometry Part A, 2008
- A Systematic Literature Review of Surgical Interventions for Limbal Stem Cell Deficiency in HumansAmerican Journal of Ophthalmology, 2008
- A biomimetic scaffold for culturing limbal stem cells: a promising alternative for clinical transplantationJournal of Tissue Engineering and Regenerative Medicine, 2008
- Preliminary Clinical Results of Descemet Membrane Endothelial KeratoplastyAmerican Journal of Ophthalmology, 2008
- Bone marrow-derived progenitor cells promote corneal wound healing following alkali injuryGraefe's Archive for Clinical and Experimental Ophthalmology, 2007
- Clinical Outcomes After Deep Anterior Lamellar Keratoplasty Using the Big-bubble Technique in Patients With KeratoconusAmerican Journal of Ophthalmology, 2007
- Plasticity of epidermal adult stem cells derived from adult goat ear skinMolecular Reproduction and Development, 2006
- Properties of Corneas Reconstructed with Cultured Human Corneal Endothelial Cells and Human Corneal StromaJapanese Journal of Ophthalmology, 2005
- Survival Analysis of Conjunctival Limbal Grafts and Amniotic Membrane Transplantation in Eyes With Total Limbal Stem Cell DeficiencyAmerican Journal of Ophthalmology, 2005
- Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivoBiochemical and Biophysical Research Communications, 2005